Author:
Princk Christina,Kollhorst Bianca,Haug Ulrike
Reference19 articles.
1. Teratogen update: reproductive risks of Leflunomide (Arava™); A pyrimidine synthesis inhibitor: counseling women taking Leflunomide before or during pregnancy and men taking Leflunomide who are contemplating fathering a child;Brent;Teratology,2001
2. A critical review of the reproductive safety of Leflunomide;Pfaller;Clin. Rheuma,2020
3. Leflunomide;Prakash;Drugs,1999
4. European Medicines Agency (EMA). Arava: EPAR - Product information. 〈https://www.ema.europa.eu/en/documents/product-information/arava-epar-product-information_en.pdf〉, 2022 (accessed 5 October 2022).
5. Grandt D., Lappe V., Schubert I. BARMER Arzneimittelreport 2021. Arzneimitteltherapie in der Schwangerschaft und bei Frauen im gebärfähigen Alter. Schriftenreihe zur Gesundheitsanalyse BARMER. 2021.